Negative rating slashes 10% from Intuitive Surgical | Wall Street Beat

December 20, 2012 by MassDevice staff

A highly negative research report from Citron spooks investors into shaving 11% from Intuitive Surgical shares in 2 days. Wall Street Beat

A research report blasting Intuitive Surgical (NSDQ:ISRG) spooked investors on Wall Street yesterday and today, prompting a selloff that's shaved some 11% from the medical device company's share price.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.